Know How Meds for Postmenopausal Osteoporosis Stack Up

October 2020

The plethora of med options will raise questions about how to treat postmenopausal osteoporosis...especially with conflicting guidelines.

Which med should be used first? Stick with oral alendronate for most patients. It’s about $60/year...versus $1,700 for risedronate.

If patients can’t take an oral bisphosphonate, try once-yearly IV zoledronic acid (Reclast). It’s about $270/year plus infusion costs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Clarify Which Patients Need a COVID-19 Viral Test
Influenza Compare Oseltamivir and Baloxavir for Treating or Preventing Flu
Supplements Know Which Supplements Promoted for COVID-19 May Be Risky
Stroke Don’t Jump to Ticagrelor Plus Aspirin After Stroke
Immunizations Answer Questions About Vaccinations During COVID-19
Allergic Reactions Weigh Pros and Cons of Palforzia for Peanut Allergy
Osteoporosis Know How Meds for Postmenopausal Osteoporosis Stack Up
Substance Use Disorder Address Barriers to Treating Opioid Use Disorder During COVID-19
Med Safety Put Skin Cancer Risk With Hydrochlorothiazide in Perspective
Infectious Diseases Clarify Remdesivir and Convalescent Plasma Use for COVID-19
Acute Care Know When to Add ECG Monitoring With Droperidol